The role of prostate‐specific antigen in the clinical evaluation of prostatic disease
Open Access
- 17 February 2004
- journal article
- review article
- Published by Wiley in BJU International
- Vol. 93 (s1) , 10-15
- https://doi.org/10.1111/j.1464-410x.2003.04634.x
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- The New Human Tissue Kallikrein Gene Family: Structure, Function, and Association to DiseaseEndocrine Reviews, 2001
- Activation of Prostate-Specific Antigen Precursor (pro-PSA) by Prostin, a Novel Human Prostatic Serine Protease Identified by Degenerate PCR,Biochemistry, 2001
- Immunohistochemical finding of α‐1‐antichymotrypsin in tissues of benign prostatic hyperplasia and prostate cancerInternational Journal of Urology, 1999
- Activation of the Zymogen Form of Prostate-Specific Antigen by Human Glandular Kallikrein 2Biochemical and Biophysical Research Communications, 1997
- In vivo and in vitro complex formation of prostate specific antigen with αi‐anti‐chymotrypsinThe Prostate, 1995
- Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasmaJournal of Clinical Endocrinology & Metabolism, 1992
- Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate CancerNew England Journal of Medicine, 1991
- Enzymatic activity of prostate‐specific antigen and its reactions with extracellular serine proteinase inhibitorsEuropean Journal of Biochemistry, 1990
- The chymotrypsin‐like activity of human prostate‐specific antigen, γ‐seminoproteinFEBS Letters, 1987
- Seminal vesicle-secreted proteins and their reactions during gelation and liquefaction of human semen.Journal of Clinical Investigation, 1987